(S (NP-SBJ (NP HIV-1/NN LTR/NN activity/NN) (PP in/IN (NP human/JJ CD40-activated/JJ B/NN lymphocytes/NNS))) (VP is/VBZ (ADJP-PRD dependent/JJ (PP on/IN (NP NF-kappaB/NN)))) ./.)
(S (NP-SBJ CD40-stimulated/JJ human/JJ B/NN lymphocytes/NNS) (VP are/VBP (ADJP-PRD highly/RB permissive/JJ (PP to/TO (NP (NP a/DT productive/JJ infection/NN) (PP by/IN (NP the/DT human/JJ immunodeficiency/NN virus/NN type/NN 1/CD)))))) ./.)
(S (PP In/IN (NP these/DT cells/NNS)) ,/, (NP-SBJ (NP nuclear/JJ factors/NNS) (VP involved/VBN (NP */-NONE-) (PP in/IN (NP (NP activation/NN) (PP of/IN (NP (NP the/DT HIV-1/NN LTR/NN) ,/, (SBAR (WHNP-45 which/WDT) (S (NP-SBJ *T*-45/-NONE-) (VP contains/VBZ (NP (NP the/DT transcriptional/JJ control/NN elements/NNS) (PP of/IN (NP the/DT virus/NN)))))) ,/,)))))) (VP are/VBP (ADJP-PRD unknown/JJ)) ./.)
(S (NP-SBJ (NP Transient/JJ expression/NN assays/NNS) (PP with/IN (NP (NP plasmids/NNS) (VP containing/VBG (NP (NP deleted/VBN parts/NNS) (PP of/IN (NP (NP the/DT LTR/NN region/NN) (VP linked/VBN (NP */-NONE-) (PP to/TO (NP a/DT reporter/NN gene/NN)))))))))) (VP showed/VBD (SBAR that/IN (S (NP-SBJ the/DT NF-kappaB/NN binding/NN site/NN) (VP was/VBD (ADJP-PRD essential/JJ (PP for/IN (NP (NP HIV-1/NN LTR/NN activity/NN) (PP in/IN (NP CD40-stimulated/JJ B/NN lymphocytes/NNS))))))))) ./.)
(S (PP In/IN (NP addition/NN)) ,/, (NP-SBJ (NP-COOD (NP electrophoretic/JJ mobility/NN shift/NN) and/CC (NP supershift/NN)) assays/NNS) (VP revealed/VBD (SBAR that/IN (S (NP-SBJ (NP important/JJ NF-kappaB/NN binding/NN activity/NN) (VP composed/VBN (NP */-NONE-) (PP of/IN (NP (ADVP at/IN least/JJS) (NP-COOD (NP p50/NN) ,/, (NP p65/NN) ,/, and/CC (NP c-Rel/NN NF-kappaB/NN)) subunits/NNS)))) (VP was/VBD (ADJP-PRD present/JJ (PP in/IN (NP (NP nuclei/NNS) (PP of/IN (NP CD40-stimulated/JJ B/NN cells/NNS))))))))) ./.)
(S (NP-SBJ These/DT results/NNS) (VP-COOD (VP confirm/VBP (PP at/IN (NP a/DT molecular/JJ level/NN)) (NP-102 (NP the/DT ability/NN (S *ICH*-46/-NONE-)) (PP of/IN (NP HIV-1/NN)) (S-46 (NP-SBJ */-NONE-) (VP to/TO (VP replicate/VB (PP in/IN (NP B/NN cells/NNS))))))) and/CC (VP (SBAR=102 that/IN (S (NP-SBJ-47 this/DT activity/NN) (VP is/VBZ (VP (ADVP strongly/RB) associated/VBN (NP *-47/-NONE-) (PP with/IN (NP NF-kappaB/NN)))))))) ./.)
